Major pharmaceutical companies have agreed to cap out-of-pocket costs for some asthma patients, but critics argue it's only part of the solution to high drug prices.
HALO NEWSLETTER
Keep reading HALO with a Free Subscription
unlock this story instantly and join members and pros reading HALO daily
-It's
Free